These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 10679296)
1. Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus. Kobayashi S; Morimoto K; Shimizu T; Takahashi M; Kurosawa H; Shirasawa T Biochem Biophys Res Commun; 2000 Feb; 268(3):860-7. PubMed ID: 10679296 [TBL] [Abstract][Full Text] [Related]
2. EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis. Stickens D; Brown D; Evans GA Dev Dyn; 2000 Jul; 218(3):452-64. PubMed ID: 10878610 [TBL] [Abstract][Full Text] [Related]
3. Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes. Bernard MA; Hall CE; Hogue DA; Cole WG; Scott A; Snuggs MB; Clines GA; Lüdecke HJ; Lovett M; Van Winkle WB; Hecht JT Cell Motil Cytoskeleton; 2001 Feb; 48(2):149-62. PubMed ID: 11169766 [TBL] [Abstract][Full Text] [Related]
4. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. McCormick C; Duncan G; Goutsos KT; Tufaro F Proc Natl Acad Sci U S A; 2000 Jan; 97(2):668-73. PubMed ID: 10639137 [TBL] [Abstract][Full Text] [Related]
5. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes. Wuyts W; Van Hul W Hum Mutat; 2000; 15(3):220-7. PubMed ID: 10679937 [TBL] [Abstract][Full Text] [Related]
6. Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations. Bernard MA; Hogue DA; Cole WG; Sanford T; Snuggs MB; Montufar-Solis D; Duke PJ; Carson DD; Scott A; Van Winkle WB; Hecht JT J Bone Miner Res; 2000 Mar; 15(3):442-50. PubMed ID: 10750558 [TBL] [Abstract][Full Text] [Related]
7. Germline mutations in the EXT1 and EXT2 genes in Korean patients with hereditary multiple exostoses. Park KJ; Shin KH; Ku JL; Cho TJ; Lee SH; Choi IH; Phillipe C; Monaco AP; Porter DE; Park JG J Hum Genet; 1999; 44(4):230-4. PubMed ID: 10429361 [TBL] [Abstract][Full Text] [Related]
8. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas. Hameetman L; David G; Yavas A; White SJ; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV J Pathol; 2007 Mar; 211(4):399-409. PubMed ID: 17226760 [TBL] [Abstract][Full Text] [Related]
9. A novel deletion mutation of the EXT2 gene in a large Chinese pedigree with hereditary multiple exostosis. Xiao CY; Wang J; Zhang SZ; Van Hul W; Wuyts W; Qiu WM; Wu H; Zhang G Br J Cancer; 2001 Jul; 85(2):176-81. PubMed ID: 11461073 [TBL] [Abstract][Full Text] [Related]
10. An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas. Wuyts W; Radersma R; Storm K; Vits L Clin Genet; 2005 Dec; 68(6):542-7. PubMed ID: 16283885 [TBL] [Abstract][Full Text] [Related]
11. Clinical outcome and genotype in patients with hereditary multiple exostoses. Jäger M; Westhoff B; Portier S; Leube B; Hardt K; Royer-Pokora B; Gossheger G; Krauspe R J Orthop Res; 2007 Dec; 25(12):1541-51. PubMed ID: 17676624 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses. Raskind WH; Conrad EU; Matsushita M; Wijsman EM; Wells DE; Chapman N; Sandell LJ; Wagner M; Houck J Hum Mutat; 1998; 11(3):231-9. PubMed ID: 9521425 [TBL] [Abstract][Full Text] [Related]
13. Transgenic expression of the EXT2 gene in developing chondrocytes enhances the synthesis of heparan sulfate and bone formation in mice. Morimoto K; Shimizu T; Furukawa K; Morio H; Kurosawa H; Shirasawa T Biochem Biophys Res Commun; 2002 Apr; 292(4):999-1009. PubMed ID: 11944914 [TBL] [Abstract][Full Text] [Related]
14. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. McCormick C; Leduc Y; Martindale D; Mattison K; Esford LE; Dyer AP; Tufaro F Nat Genet; 1998 Jun; 19(2):158-61. PubMed ID: 9620772 [TBL] [Abstract][Full Text] [Related]
15. Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis. Hall CR; Cole WG; Haynes R; Hecht JT Am J Med Genet; 2002 Sep; 112(1):1-5. PubMed ID: 12239711 [TBL] [Abstract][Full Text] [Related]
16. Novel EXT1 and EXT2 mutations identified by DHPLC in Italian patients with multiple osteochondromas. Pedrini E; De Luca A; Valente EM; Maini V; Capponcelli S; Mordenti M; Mingarelli R; Sangiorgi L; Dallapiccola B Hum Mutat; 2005 Sep; 26(3):280. PubMed ID: 16088908 [TBL] [Abstract][Full Text] [Related]
17. Association of autism in two patients with hereditary multiple exostoses caused by novel deletion mutations of EXT1. Li H; Yamagata T; Mori M; Momoi MY J Hum Genet; 2002; 47(5):262-5. PubMed ID: 12032595 [TBL] [Abstract][Full Text] [Related]
18. 20 novel point mutations and one large deletion in EXT1 and EXT2 genes: report of diagnostic screening in a large Italian cohort of patients affected by hereditary multiple exostosis. Ciavarella M; Coco M; Baorda F; Stanziale P; Chetta M; Bisceglia L; Palumbo P; Bengala M; Raiteri P; Silengo M; Caldarini C; Facchini R; Lala R; Cavaliere ML; De Brasi D; Pasini B; Zelante L; Guarnieri V; D'Agruma L Gene; 2013 Feb; 515(2):339-48. PubMed ID: 23262345 [TBL] [Abstract][Full Text] [Related]
19. Comparison of fluorescent single-strand conformation polymorphism analysis and denaturing high-performance liquid chromatography for detection of EXT1 and EXT2 mutations in hereditary multiple exostoses. Dobson-Stone C; Cox RD; Lonie L; Southam L; Fraser M; Wise C; Bernier F; Hodgson S; Porter DE; Simpson AH; Monaco AP Eur J Hum Genet; 2000 Jan; 8(1):24-32. PubMed ID: 10713884 [TBL] [Abstract][Full Text] [Related]
20. [From gene to disease; hereditary multiple exostoses]. Wuyts W; Bovée JV; Hogendoorn PC Ned Tijdschr Geneeskd; 2002 Jan; 146(4):162-4. PubMed ID: 11845565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]